marketcaparena
Search

    HAE

    HAEMONETICS CORP

    Company overview

    Market capitalization
    $4.81B
    Employees
    3,009
    Latest publication
    2026-09-29
    About HAEMONETICS CORP

    Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20272026-06-27 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
    Total Revenue339,380,000USD346,351,000USD338,967,000USD327,315,000USD321,394,000USD330,599,000USD348,542,000USD345,511,000USD
    Cost Of Revenue136,577,000USD148,139,000USD147,561,000USD143,894,000USD129,535,000USD148,675,000USD148,627,000USD154,309,000USD
    Gross Profit202,803,000USD198,212,000USD191,406,000USD183,421,000USD191,859,000USD181,924,000USD199,915,000USD191,202,000USD
    Research Development16,200,000USD14,446,000USD14,287,000USD14,523,000USD16,261,000USD15,959,000USD15,829,000USD14,139,000USD
    Selling General Administrative118,941,000USD120,933,000USD106,900,000USD101,615,000USD110,719,000USD115,136,000USD106,459,000USD106,946,000USD
    Total Operating Expenses145,345,000USD146,765,000USD121,846,000USD116,142,000USD137,987,000USD130,460,000USD140,886,000USD139,505,000USD
    Operating Income57,458,000USD51,447,000USD69,560,000USD67,279,000USD53,872,000USD51,464,000USD59,029,000USD51,697,000USD
    Total Other Income Expense Net-9,884,000USD-79,846,000USD-9,585,000USD-15,994,000USD-8,703,000USD19,273,000USD-9,112,000USD-6,993,000USD
    Income Before Tax47,574,000USD-28,399,000USD59,975,000USD51,285,000USD45,169,000USD70,737,000USD49,917,000USD44,704,000USD
    Income Tax Expense14,564,000USD-8,252,000USD15,235,000USD12,601,000USD11,138,000USD12,756,000USD12,423,000USD10,873,000USD
    Net Income33,010,000USD-20,147,000USD44,740,000USD38,684,000USD34,031,000USD57,981,000USD37,494,000USD33,831,000USD
    Unclassified Operating Expenses—11,386,000USD——11,007,000USD—18,598,000USD18,420,000USD
    Interest Expense—5,374,000USD8,122,000USD7,212,000USD4,073,000USD598,000USD9,112,000USD6,993,000USD
    Net Interest Income—-5,374,000USD-7,421,000USD-7,206,000USD-8,703,000USD-598,000USD-9,112,000USD-6,993,000USD
    Tax Provision—-8,252,000USD15,235,000USD12,601,000USD11,138,000USD12,756,000USD12,423,000USD10,873,000USD
    Net Income From Continuing Ops—-20,147,000USD44,740,000USD38,684,000USD34,031,000USD57,981,000USD37,494,000USD33,831,000USD
    Ebit—-23,025,000USD68,097,000USD58,497,000USD64,938,000USD70,737,000USD66,111,000USD59,762,000USD
    Ebitda—4,294,000USD95,482,000USD86,752,000USD93,696,000USD98,945,000USD95,136,000USD88,979,000USD
    Depreciation And Amortization—27,319,000USD27,385,000USD28,255,000USD28,758,000USD28,208,000USD29,025,000USD29,217,000USD
    Reconciled Depreciation—27,319,000USD27,385,000USD28,255,000USD28,758,000USD28,208,000USD29,025,000USD29,217,000USD
    Interest Income——7,421,000USD7,206,000USD8,703,000USD598,000USD9,112,000USD6,993,000USD
    Net Income Applicable To Common Shares——44,740,000USD38,684,000USD34,031,000USD57,981,000USD37,494,000USD33,831,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Revenue1,334,027,000USD1,360,824,000USD1,309,055,000USD1,168,660,000USD993,196,000USD870,463,000USD988,479,000USD967,579,000USD
    Cost Of Revenue590,439,000USD582,278,000USD597,140,000USD545,787,000USD462,426,000USD442,017,000USD500,657,000USD550,043,000USD
    Gross Profit743,588,000USD778,546,000USD711,915,000USD622,873,000USD530,770,000USD428,446,000USD487,822,000USD417,536,000USD
    Research Development59,766,000USD69,422,000USD63,035,000USD58,631,000USD55,201,000USD40,657,000USD39,083,000USD35,714,000USD
    Selling General Administrative442,421,000USD414,351,000USD413,718,000USD366,752,000USD327,803,000USD261,131,000USD262,034,000USD293,777,000USD
    Total Operating Expenses502,187,000USD556,729,000USD547,032,000USD466,840,000USD450,020,000USD338,699,000USD384,471,000USD333,991,000USD
    Operating Income241,401,000USD221,817,000USD164,883,000USD156,033,000USD80,750,000USD89,747,000USD103,351,000USD83,545,000USD
    Interest Expense28,704,000USD9,746,000USD13,018,000USD14,630,000USD17,121,000USD16,834,000USD16,199,000USD9,912,000USD
    Net Interest Income-28,704,000USD-9,746,000USD-13,018,000USD-14,630,000USD-17,121,000USD-16,834,000USD-16,199,000USD-9,912,000USD
    Income Before Tax128,030,000USD212,071,000USD151,865,000USD141,403,000USD63,629,000USD72,913,000USD87,152,000USD73,633,000USD
    Income Tax Expense30,722,000USD44,392,000USD34,307,000USD26,002,000USD20,254,000USD-6,556,000USD10,626,000USD18,614,000USD
    Tax Provision30,722,000USD44,392,000USD34,307,000USD26,002,000USD20,254,000USD-6,556,000USD10,626,000USD18,614,000USD
    Net Income97,308,000USD167,679,000USD117,558,000USD115,401,000USD43,375,000USD79,469,000USD76,526,000USD55,019,000USD
    Net Income From Continuing Ops97,308,000USD167,679,000USD117,558,000USD115,401,000USD43,375,000USD79,469,000USD76,526,000USD55,019,000USD
    Ebit156,734,000USD247,100,000USD206,837,000USD167,200,000USD105,171,000USD100,096,000USD165,745,000USD83,545,000USD
    Ebitda312,449,000USD355,986,000USD295,452,000USD252,007,000USD191,718,000USD184,383,000USD257,934,000USD192,963,000USD
    Depreciation And Amortization155,715,000USD108,886,000USD88,615,000USD84,807,000USD86,547,000USD84,287,000USD92,189,000USD109,418,000USD
    Reconciled Depreciation111,717,000USD115,586,000USD97,215,000USD93,307,000USD97,747,000USD84,287,000USD110,289,000USD109,418,000USD
    Total Other Income Expense Net-113,371,000USD-9,746,000USD-13,018,000USD-14,630,000USD-17,121,000USD-16,834,000USD-16,199,000USD-9,912,000USD
    Selling And Marketing Expenses—7,700,000USD7,100,000USD7,200,000USD4,400,000USD2,700,000USD4,300,000USD4,500,000USD
    Unclassified Operating Expenses—65,256,000USD63,179,000USD34,257,000USD62,616,000USD34,211,000USD79,054,000USD—
    Interest Income—9,746,000USD13,018,000USD14,630,000USD17,121,000USD16,834,000USD16,199,000USD9,912,000USD
    Net Income Applicable To Common Shares—167,679,000USD117,558,000USD115,401,000USD43,375,000USD79,469,000USD76,526,000USD55,019,000USD
    Non Operating Income Net Other———-14,630,000USD-17,121,000USD-16,834,000USD-16,199,000USD-9,912,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20272026-06-27 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
    Total Assets2,365,400,000USD2,395,925,000USD2,490,890,000USD2,442,156,000USD2,462,094,000USD2,450,948,000USD2,531,270,000USD2,525,224,000USD
    Cash And Equivalents223,384,000USD—363,367,000USD296,426,000USD292,898,000USD306,763,000USD320,846,000USD299,283,000USD
    Total Current Assets810,832,000USD834,879,000USD943,674,000USD899,682,000USD913,160,000USD934,975,000USD1,005,868,000USD955,902,000USD
    Other Current Assets64,638,000USD66,214,000USD63,415,000USD59,984,000USD58,983,000USD60,414,000USD113,459,000USD60,980,000USD
    Other Non Current Assets149,960,000USD———————
    Total Liabilities1,528,299,000USD———————
    Total Current Liabilities263,235,000USD282,599,000USD539,868,000USD548,318,000USD531,407,000USD578,113,000USD253,233,000USD273,946,000USD
    Other Current Liabilities163,796,000USD———————
    Other Non Current Liabilities57,171,000USD———————
    Total Stockholder Equity837,101,000USD796,320,000USD911,451,000USD849,173,000USD882,300,000USD820,836,000USD906,860,000USD878,851,000USD
    Total Equity Including Noncontrolling Interest837,101,000USD———————
    Short Long Term Debt4,956,000USD5,015,000USD304,746,000USD304,335,000USD303,949,000USD303,558,000USD5,075,000USD5,434,000USD
    Long Term Debt1,169,202,000USD1,219,565,000USD919,987,000USD920,393,000USD920,833,000USD921,230,000USD1,219,762,000USD1,219,523,000USD
    Net Receivables216,071,000USD216,855,000USD195,707,000USD207,066,000USD200,752,000USD202,657,000USD211,949,000USD213,534,000USD
    Inventory306,739,000USD306,370,000USD321,185,000USD336,206,000USD360,527,000USD365,141,000USD359,614,000USD382,105,000USD
    Property Plant Equipment Net303,778,000USD305,761,000USD297,234,000USD292,476,000USD286,865,000USD284,052,000USD286,107,000USD300,478,000USD
    Goodwill656,884,000USD———————
    Intangible Assets434,512,000USD447,655,000USD419,734,000USD428,357,000USD450,634,000USD455,742,000USD465,615,000USD487,837,000USD
    Accounts Payable56,338,000USD51,056,000USD48,694,000USD61,691,000USD46,010,000USD66,999,000USD62,990,000USD69,242,000USD
    Common Stock455,000USD453,000USD468,000USD467,000USD482,000USD482,000USD502,000USD504,000USD
    Retained Earnings311,516,000USD279,344,000USD381,091,000USD336,323,000USD356,046,000USD352,174,000USD392,230,000USD368,536,000USD
    Accumulated Other Comprehensive Income-41,629,000USD-37,614,000USD-34,610,000USD-40,531,000USD-36,242,000USD-55,084,000USD-55,501,000USD-34,564,000USD
    Total Liab—1,599,605,000USD1,579,439,000USD1,592,983,000USD1,579,794,000USD1,630,112,000USD1,624,410,000USD1,646,373,000USD
    Other Current Liab—184,218,000USD186,428,000USD182,292,000USD132,248,000USD164,208,000USD149,568,000USD162,570,000USD
    Capital Stock—453,000USD468,000USD467,000USD482,000USD482,000USD502,000USD504,000USD
    Good Will—656,368,000USD606,825,000USD606,101,000USD607,299,000USD604,269,000USD605,266,000USD616,162,000USD
    Cash—245,440,000USD363,367,000USD296,426,000USD292,898,000USD306,763,000USD320,846,000USD299,283,000USD
    Cash And Short Term Investments—245,440,000USD363,367,000USD296,426,000USD292,898,000USD306,763,000USD320,846,000USD299,283,000USD
    Current Deferred Revenue—42,310,000USD——49,200,000USD43,348,000USD35,600,000USD36,700,000USD
    Net Debt—979,140,000USD861,366,000USD928,302,000USD931,884,000USD918,025,000USD903,991,000USD925,674,000USD
    Short Term Debt—5,015,000USD304,746,000USD304,335,000USD303,949,000USD303,558,000USD5,075,000USD5,434,000USD
    Short Long Term Debt Total—1,224,580,000USD1,224,733,000USD1,224,728,000USD1,224,782,000USD1,224,788,000USD1,224,837,000USD1,224,957,000USD
    Property Plant Equipment Gross—841,829,000USD836,814,000USD815,309,000USD795,098,000USD837,194,000USD867,457,000USD939,094,000USD
    Common Stock Shares Outstanding—46,224,000shares46,987,000shares47,664,000shares48,353,000shares49,476,000shares50,639,000shares51,240,000shares
    Non Current Assets Total—1,561,046,000USD1,547,216,000USD1,542,474,000USD1,548,934,000USD1,515,972,000USD1,525,402,000USD1,569,322,000USD
    Non Current Liabilities Total—1,317,006,000USD1,039,571,000USD1,044,665,000USD1,048,387,000USD1,051,999,000USD1,371,177,000USD1,372,427,000USD
    Non Current Liabilities Other—59,393,000USD63,605,000USD66,071,000USD68,066,000USD68,194,000USD89,964,000USD90,011,000USD
    Non Currrent Assets Other—141,741,000USD216,094,000USD207,969,000USD183,393,000USD164,106,000USD160,414,000USD155,762,000USD
    Net Working Capital—552,280,000USD403,806,000USD351,364,000USD381,753,000USD356,862,000USD752,635,000USD681,956,000USD
    Unclassified Current Liabilities—-5,015,000USD-304,746,000USD-304,335,000USD-303,949,000USD-303,558,000USD-5,075,000USD-5,434,000USD
    Unclassified Non Current Liabilities—38,048,000USD55,979,000USD58,201,000USD59,488,000USD62,575,000USD61,451,000USD62,893,000USD
    Unclassified Equity—553,684,000USD564,034,000USD552,447,000USD561,532,000USD522,782,000USD569,127,000USD543,871,000USD
    Other Assets——223,423,000USD215,540,000USD204,136,000USD1,000USD168,414,000USD164,845,000USD
    Unclassified Non Current Assets——-216,094,000USD-207,969,000USD-183,393,000USD—-160,414,000USD-155,762,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Assets2,395,925,000USD2,450,948,000USD2,195,591,000USD1,934,825,000USD1,859,734,000USD1,819,923,000USD1,267,110,000USD1,274,767,000USD
    Intangible Assets447,655,000USD455,742,000USD406,117,000USD275,771,000USD310,261,000USD365,483,000USD133,106,000USD127,693,000USD
    Other Current Assets66,214,000USD60,414,000USD66,339,000USD46,735,000USD44,132,000USD51,072,000USD30,845,000USD54,812,000USD
    Total Liab1,599,605,000USD1,630,112,000USD1,235,632,000USD1,116,828,000USD1,110,310,000USD1,088,253,000USD680,001,000USD606,899,000USD
    Total Stockholder Equity796,320,000USD820,836,000USD959,959,000USD817,997,000USD749,424,000USD731,670,000USD587,109,000USD667,868,000USD
    Other Current Liab184,218,000USD164,208,000USD185,554,000USD145,894,000USD121,834,000USD128,549,000USD94,392,000USD105,007,000USD
    Common Stock453,000USD482,000USD508,000USD504,000USD511,000USD509,000USD503,000USD510,000USD
    Capital Stock453,000USD482,000USD508,000USD504,000USD511,000USD509,000USD503,000USD510,000USD
    Retained Earnings279,344,000USD352,174,000USD360,456,000USD253,168,000USD202,391,000USD157,981,000USD78,512,000USD161,418,000USD
    Good Will656,368,000USD604,269,000USD565,082,000USD466,231,000USD467,287,000USD466,444,000USD210,652,000USD210,819,000USD
    Cash245,440,000USD306,763,000USD178,800,000USD284,466,000USD259,496,000USD192,305,000USD137,311,000USD169,351,000USD
    Cash And Short Term Investments245,440,000USD306,763,000USD178,800,000USD284,466,000USD259,496,000USD192,305,000USD137,311,000USD169,351,000USD
    Total Current Assets834,879,000USD934,975,000USD768,903,000USD769,722,000USD756,031,000USD693,546,000USD603,639,000USD576,121,000USD
    Total Current Liabilities282,599,000USD578,113,000USD300,383,000USD251,816,000USD442,266,000USD253,495,000USD274,822,000USD235,759,000USD
    Current Deferred Revenue42,310,000USD43,348,000USD31,242,000USD30,209,000USD26,809,000USD26,272,000USD28,843,000USD27,279,000USD
    Net Debt979,140,000USD918,025,000USD628,993,000USD481,420,000USD521,289,000USD585,971,000USD304,502,000USD180,769,000USD
    Short Term Debt5,015,000USD303,558,000USD10,229,000USD11,784,000USD221,344,000USD24,724,000USD84,286,000USD27,666,000USD
    Short Long Term Debt5,015,000USD303,558,000USD10,229,000USD11,784,000USD214,148,000USD17,016,000USD76,980,000USD27,666,000USD
    Short Long Term Debt Total1,224,580,000USD1,224,788,000USD807,793,000USD765,886,000USD780,785,000USD778,276,000USD441,813,000USD350,120,000USD
    Long Term Debt1,219,565,000USD921,230,000USD797,564,000USD754,102,000USD559,441,000USD690,592,000USD305,513,000USD322,454,000USD
    Net Receivables216,855,000USD202,657,000USD206,562,000USD179,142,000USD159,376,000USD127,555,000USD165,207,000USD185,027,000USD
    Inventory306,370,000USD365,141,000USD317,202,000USD259,379,000USD293,027,000USD322,614,000USD270,276,000USD194,337,000USD
    Accounts Payable51,056,000USD66,999,000USD73,358,000USD63,929,000USD58,371,000USD50,293,000USD50,730,000USD63,361,000USD
    Property Plant Equipment Net305,761,000USD284,052,000USD366,630,000USD310,885,000USD258,482,000USD217,559,000USD253,399,000USD343,979,000USD
    Property Plant Equipment Gross841,829,000USD837,194,000USD959,177,000USD944,215,000USD869,147,000USD217,559,000USD305,635,000USD343,979,000USD
    Accumulated Other Comprehensive Income-37,614,000USD-55,084,000USD-35,632,000USD-30,381,000USD-25,954,000USD-29,547,000USD-45,135,000USD-30,380,000USD
    Common Stock Shares Outstanding47,354,000shares50,730,000shares51,397,000shares51,420,000shares51,353,000shares51,292,000shares51,815,000shares52,942,000shares
    Non Current Assets Total1,561,046,000USD1,515,972,000USD1,426,688,000USD1,165,103,000USD1,103,703,000USD1,126,377,000USD663,471,000USD698,646,000USD
    Non Current Liabilities Total1,317,006,000USD1,051,999,000USD935,249,000USD865,012,000USD668,044,000USD834,758,000USD405,179,000USD371,140,000USD
    Non Current Liabilities Other59,393,000USD68,194,000USD75,041,000USD110,910,000USD108,603,000USD144,166,000USD89,104,000USD5,814,000USD
    Non Currrent Assets Other141,741,000USD164,106,000USD81,120,000USD106,975,000USD63,205,000USD70,882,000USD62,384,000USD16,155,000USD
    Net Working Capital552,280,000USD356,862,000USD468,520,000USD517,906,000USD313,765,000USD440,051,000USD328,817,000USD340,362,000USD
    Unclassified Current Liabilities-5,015,000USD-303,558,000USD-10,229,000USD-11,784,000USD-200,240,000USD6,641,000USD-60,409,000USD-15,220,000USD
    Unclassified Non Current Liabilities38,048,000USD62,575,000USD62,644,000USD-36,195,000USD-137,330,000USD-120,730,000USD-38,177,000USD-25,720,000USD
    Unclassified Equity553,684,000USD522,782,000USD634,119,000USD594,202,000USD571,965,000USD602,218,000USD552,726,000USD535,810,000USD
    Other Assets—1,000USD1USD58,803,000USD67,673,000USD17,035,000USD14,078,000USD16,155,000USD
    Cash And Equivalents—306,763,000USD178,800,000USD284,466,000USD259,496,000USD192,305,000USD137,311,000USD169,351,000USD
    Short Term Investments——1,673,000USD1,110,000USD————
    Deferred Long Term Liab———36,195,000USD28,727,000USD43,825,000USD10,562,000USD19,906,000USD
    Net Tangible Assets———75,995,000USD-28,124,000USD-100,257,000USD243,351,000USD329,356,000USD
    Unclassified Non Current Assets———-53,562,000USD-63,205,000USD—-10,148,000USD-16,155,000USD
    Other Liab————108,603,000USD76,905,000USD38,177,000USD48,686,000USD
    Unclassified Current Assets———————-27,406,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20272026-06-27 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
    Net Income33,010,000USD-20,147,000USD44,740,000USD38,684,000USD34,031,000USD57,981,000USD37,494,000USD33,831,000USD
    Depreciation27,111,000USD27,319,000USD27,385,000USD28,255,000USD28,758,000USD28,208,000USD29,025,000USD29,217,000USD
    Stock Based Compensation9,311,000USD9,127,000USD7,799,000USD7,589,000USD9,312,000USD6,937,000USD8,214,000USD6,857,000USD
    Deferred Income Tax668,000USD———————
    Other Non Cash Items-4,455,000USD55,407,000USD3,893,000USD11,429,000USD4,007,000USD-20,936,000USD6,772,000USD8,606,000USD
    Change To Account Receivables297,000USD-22,237,000USD11,058,000USD-7,259,000USD3,557,000USD10,335,000USD-1,771,000USD-9,578,000USD
    Change To Inventory-1,004,000USD8,462,000USD13,841,000USD21,762,000USD3,296,000USD925,000USD-17,332,000USD-10,780,000USD
    Change To Liabilities-12,615,000USD———————
    Change In Working Capital-13,322,000USD-6,069,000USD11,809,000USD26,089,000USD-55,482,000USD40,993,000USD-35,322,000USD-27,365,000USD
    Operating Cash Flow52,323,000USD———————
    Capital Expenditures-7,906,000USD-17,661,000USD-6,349,000USD-5,016,000USD-3,754,000USD-15,643,000USD-8,546,000USD-9,433,000USD
    Net Investments-9,000,000USD———————
    Unclassified Investing Cash Flow-5,328,000USD-59,654,000USD25,549,000USD22,705,000USD15,214,000USD10,559,000USD17,371,000USD21,612,000USD
    Investing Cash Flow-22,234,000USD———————
    Net Debt Issuance-1,563,000USD———————
    Net Common Stock Issuance-3,500,000USD———————
    Other Financing Activities-14,000USD———————
    Unclassified Financing Cash Flow-46,451,000USD—-71,230,000USD—8,719,000USD—12,841,000USD-9,750,000USD
    Financing Cash Flow-51,528,000USD———————
    Effect Of Forex Changes On Cash-617,000USD———————
    Change In Cash-22,056,000USD-117,927,000USD66,941,000USD3,528,000USD-13,865,000USD-14,083,000USD21,563,000USD-45,146,000USD
    End Cash Flow223,384,000USD———————
    Total Cash From Operating Activities—70,941,000USD93,564,000USD111,321,000USD17,395,000USD116,557,000USD43,766,000USD48,823,000USD
    Free Cash Flow—53,280,000USD87,215,000USD106,305,000USD13,641,000USD100,914,000USD35,220,000USD39,390,000USD
    Total Cashflows From Investing Activities—-86,613,000USD-29,466,000USD-30,468,000USD-33,000,000USD18,040,000USD-17,371,000USD-23,367,000USD
    Net Borrowings—-1,562,000USD-1,563,000USD-1,562,000USD-1,563,000USD-1,563,000USD-1,562,000USD0USD
    Total Cash From Financing Activities—-101,499,000USD2,033,000USD-76,552,000USD-2,442,000USD-151,450,000USD1,380,000USD-74,804,000USD
    Sale Purchase Of Stock—-100,000,000USD75,000,000USD-75,000,000USD-4,781,000USD-150,000,000USD-9,750,000USD9,750,000USD
    Begin Period Cash Flow—363,367,000USD296,426,000USD292,898,000USD306,763,000USD320,846,000USD299,283,000USD344,429,000USD
    End Period Cash Flow—245,440,000USD363,367,000USD296,426,000USD292,898,000USD306,763,000USD320,846,000USD299,283,000USD
    Other Cashflows From Investing Activities—-9,298,000USD-48,666,000USD-17,689,000USD-11,460,000USD5,084,000USD-8,825,000USD-12,179,000USD
    Other Cashflows From Financing Activities—-59,000USD-174,000USD-53,000USD-4,817,000USD-27,000USD-149,000USD-74,804,000USD
    Unclassified Operating Cash Flow—5,304,000USD-2,062,000USD—-3,231,000USD3,374,000USD-2,417,000USD-2,323,000USD
    Investments———-30,468,000USD-33,000,000USD18,040,000USD-17,371,000USD-23,367,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Net Income97,308,000USD167,679,000USD117,558,000USD115,401,000USD43,375,000USD79,469,000USD76,526,000USD55,019,000USD
    Depreciation111,717,000USD115,586,000USD97,215,000USD93,307,000USD97,747,000USD84,287,000USD110,289,000USD109,418,000USD
    Stock Based Compensation33,827,000USD29,636,000USD28,332,000USD25,583,000USD24,359,000USD25,516,000USD20,454,000USD17,188,000USD
    Other Non Cash Items74,736,000USD-23,494,000USD24,386,000USD8,481,000USD16,946,000USD-919,000USD42,468,000USD27,055,000USD
    Change To Account Receivables-14,881,000USD6,956,000USD-24,193,000USD-24,421,000USD-34,974,000USD44,121,000USD18,863,000USD-38,064,000USD
    Change To Inventory47,361,000USD-64,704,000USD-60,061,000USD30,754,000USD24,307,000USD-38,909,000USD-84,721,000USD-39,322,000USD
    Change In Working Capital-23,653,000USD-91,984,000USD-74,701,000USD25,503,000USD-15,177,000USD-59,682,000USD-84,562,000USD-62,750,000USD
    Total Cash From Operating Activities293,221,000USD181,725,000USD181,751,000USD273,058,000USD172,263,000USD108,805,000USD158,217,000USD159,281,000USD
    Capital Expenditures-32,780,000USD-39,278,000USD-66,296,000USD-110,191,000USD-96,509,000USD-37,040,000USD-48,758,000USD-118,961,000USD
    Free Cash Flow260,440,999USD142,447,000USD115,455,000USD162,867,000USD75,754,000USD71,765,000USD109,459,000USD40,320,000USD
    Investments-36,071,000USD-161,895,000USD-322,389,000USD-143,788,000USD-86,345,000USD-425,442,000USD-57,176,000USD-116,148,000USD
    Total Cashflows From Investing Activities-179,547,000USD-161,895,000USD-322,389,000USD-143,788,000USD-86,345,000USD-425,442,000USD-57,176,000USD-116,148,000USD
    Net Borrowings-6,250,000USD447,312,000USD37,750,000USD269,257,000USD-17,500,000USD370,725,000USD31,875,000USD95,927,000USD
    Total Cash From Financing Activities-178,460,000USD108,818,000USD38,157,000USD-100,364,000USD-15,749,000USD367,452,000USD-131,208,000USD-50,628,000USD
    Sale Purchase Of Stock-175,000,000USD-225,000,000USD-5,885,000USD-75,000,000USD-75,000,000USD10,230,000USD-175,000,000USD-160,000,000USD
    Change In Cash-61,323,000USD127,963,000USD-105,666,000USD24,970,000USD67,191,000USD54,994,000USD-32,040,000USD-10,818,000USD
    Begin Period Cash Flow306,763,000USD178,800,000USD284,466,000USD259,496,000USD192,305,000USD137,311,000USD169,351,000USD180,169,000USD
    End Period Cash Flow245,440,000USD306,763,000USD178,800,000USD284,466,000USD259,496,000USD192,305,000USD137,311,000USD169,351,000USD
    Other Cashflows From Investing Activities-87,962,000USD-15,002,000USD-41,912,000USD1,608,000USD2,022,000USD1,815,000USD16,774,000USD2,813,000USD
    Other Cashflows From Financing Activities-5,103,000USD-111,584,000USD-6,807,000USD-15,739,000USD1,751,000USD-50,673,000USD11,917,000USD13,445,000USD
    Unclassified Investing Cash Flow-22,734,000USD54,280,000USD108,208,000USD108,583,000USD94,487,000USD35,225,000USD31,984,000USD116,148,000USD
    Unclassified Financing Cash Flow7,893,000USD-1,910,000USD13,099,000USD-271,866,000USD75,000,000USD37,170,000USD12,016,000USD13,445,000USD
    Unclassified Operating Cash Flow—-15,698,000USD-11,039,000USD4,783,000USD5,013,000USD-19,866,000USD-6,958,000USD13,351,000USD
    Change To Liabilities———39,816,000USD7,642,000USD-56,422,000USD-17,308,000USD17,736,000USD
    Dividends Paid———-7,016,000USD——-12,016,000USD-13,445,000USD
    Cash And Cash Equivalents Changes———28,906,000USD70,169,000USD50,815,000USD-30,167,000USD-10,818,000USD
    Exchange Rate Changes———————-3,323,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2027Quarterly · 2026-06-27GeographyAsia20,163,000USDDisclosure
    Q1 2027Quarterly · 2026-06-27GeographyEurope45,529,000USDDisclosure
    Q1 2027Quarterly · 2026-06-27GeographyJapan12,858,000USDDisclosure
    Q1 2027Quarterly · 2026-06-27GeographyOther Countryor Region2,986,000USDDisclosure
    Q1 2027Quarterly · 2026-06-27GeographyUnited States257,844,000USDDisclosure
    Q1 2027Quarterly · 2026-06-27SegmentApheresis191,318,000USDDisclosure
    Q1 2027Quarterly · 2026-06-27SegmentMed Surg148,062,000USDDisclosure
    Q4 2026Quarterly · 2026-03-31GeographyAsia19,968,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31GeographyEurope52,896,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31GeographyJapan18,404,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31GeographyOther Countryor Region3,113,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31GeographyUnited States251,970,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31SegmentBlood Center56,414,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31SegmentHospital159,647,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31SegmentPlasma130,290,000USDLegacy provider
    FY 2026Yearly · 2026-03-31GeographyAsia87,212,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31GeographyEurope185,019,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31GeographyJapan68,200,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31GeographyOther Countryor Region11,420,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31GeographyUnited States982,176,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31SegmentBlood Center221,267,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31SegmentHospital588,304,000USD0000313143-26-000050
    FY 2026Yearly · 2026-03-31SegmentPlasma524,456,000USD0000313143-26-000050
    Q3 2026Quarterly · 2025-12-31GeographyAsia23,029,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31GeographyEurope48,276,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31GeographyJapan18,137,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31GeographyOther Countryor Region1,812,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31GeographyUnited States247,713,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31SegmentBlood Center56,560,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31SegmentHospital143,502,000USD0000313143-26-000010
    Q3 2026Quarterly · 2025-12-31SegmentPlasma138,905,000USD0000313143-26-000010
    Q2 2026Quarterly · 2025-09-30GeographyAsia22,567,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30GeographyEurope42,965,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30GeographyJapan18,011,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30GeographyOther Countryor Region3,683,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30GeographyUnited States240,089,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30SegmentBlood Center56,454,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30SegmentHospital145,497,000USD0000313143-25-000075
    Q2 2026Quarterly · 2025-09-30SegmentPlasma125,364,000USD0000313143-25-000075
    Q1 2026Quarterly · 2025-06-30GeographyAsia21,648,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30GeographyEurope40,882,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30GeographyJapan13,648,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30GeographyOther Countryor Region2,812,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30GeographyUnited States242,404,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30SegmentBlood Center51,839,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30SegmentHospital139,658,000USD0000313143-25-000058
    Q1 2026Quarterly · 2025-06-30SegmentPlasma129,897,000USD0000313143-25-000058
    Q4 2025Quarterly · 2025-03-31GeographyAsia21,157,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31GeographyEurope42,276,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31GeographyJapan16,105,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31GeographyOther Countryor Region2,771,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31GeographyUnited States248,290,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31SegmentBlood Center56,006,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31SegmentHospital147,857,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31SegmentPlasma126,736,000USDLegacy provider
    FY 2025Yearly · 2025-03-31GeographyAsia92,305,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31GeographyEurope175,655,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31GeographyJapan62,408,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31GeographyOther Countryor Region19,538,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31GeographyUnited States1,010,918,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31SegmentBlood Center261,124,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31SegmentHospital564,269,000USD0000313143-26-000050
    FY 2025Yearly · 2025-03-31SegmentPlasma535,431,000USD0000313143-26-000050
    Q3 2025Quarterly · 2024-12-31GeographyAsia25,597,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31GeographyEurope44,163,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31GeographyJapan16,174,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31GeographyOther Countryor Region4,943,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31GeographyUnited States257,665,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31SegmentBlood Center70,345,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31SegmentHospital143,973,000USD0000313143-26-000010
    Q3 2025Quarterly · 2024-12-31SegmentPlasma134,224,000USD0000313143-26-000010
    Q2 2025Quarterly · 2024-09-30GeographyAsia25,768,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30GeographyEurope41,991,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30GeographyJapan16,424,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30GeographyOther Countryor Region5,267,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30GeographyUnited States256,061,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30SegmentBlood Center68,528,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30SegmentHospital138,422,000USD0000313143-25-000075
    Q2 2025Quarterly · 2024-09-30SegmentPlasma138,561,000USD0000313143-25-000075
    FY 2024Yearly · 2024-03-31GeographyAsia107,536,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31GeographyEurope160,142,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31GeographyJapan58,087,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31GeographyOther Countryor Region13,283,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31GeographyUnited States970,007,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31SegmentBlood Center283,231,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31SegmentHospital456,289,000USD0000313143-26-000050
    FY 2024Yearly · 2024-03-31SegmentPlasma569,535,000USD0000313143-26-000050
    FY 2023Yearly · 2023-03-31GeographyAsia104,135,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31GeographyEurope156,680,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31GeographyJapan61,295,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31GeographyOther Countryor Region3,653,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31GeographyUnited States842,897,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31SegmentBlood Center287,034,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31SegmentHospital381,710,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31SegmentPlasma499,916,000USD0000313143-25-000025
    FY 2023Yearly · 2023-03-31ProductBlood Center226,819,000USD0000313143-23-000014
    FY 2023Yearly · 2023-03-31ProductHospital378,107,000USD0000313143-23-000014
    FY 2023Yearly · 2023-03-31ProductPlasma563,734,000USD0000313143-23-000014
    Q3 2023Quarterly · 2022-12-31ProductBlood Center Productsand Services58,273,000USD0000313143-23-000006
    Q3 2023Quarterly · 2022-12-31ProductHospital Productsand Services93,129,000USD0000313143-23-000006

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.